Balyasny Asset Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,703,180
| Closed | -$32.9M | – | 2435 |
|
|
2025
Q1 | $32.9M | Buy |
1,703,180
+1,315,938
| +340% | +$25.4M | 0.05% | 317 |
|
|
2024
Q4 | $6.91M | Sell |
387,242
-43,934
| -10% | -$784K | 0.01% | 762 |
|
|
2024
Q3 | $9.44M | Sell |
431,176
-578,981
| -57% | -$12.7M | 0.02% | 692 |
|
|
2024
Q2 | $7.88M | Buy |
+1,010,157
| New | +$7.88M | 0.01% | 699 |
|
|
2023
Q3 | – | Sell |
-10,157
| Closed | -$25.5K | – | 2172 |
|
|
2023
Q2 | $25.5K | Sell |
10,157
-25,406
| -71% | -$63.8K | ﹤0.01% | 1752 |
|
|
2023
Q1 | $62.2K | Buy |
+35,563
| New | +$62.2K | ﹤0.01% | 1925 |
|